TY - JOUR
T1 - Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes
AU - Khera, Rohan
AU - Liu, Yusi
AU - de Lemos, James A.
AU - Das, Sandeep R.
AU - Pandey, Ambarish
AU - Omar, Wally
AU - Kumbhani, Dharam J.
AU - Girotra, Saket
AU - Yeh, Robert W.
AU - Rutan, Christine
AU - Walchok, Jason
AU - Lin, Zhenqiu
AU - Bradley, Steven M.
AU - Velazquez, Eric J.
AU - Churchwell, Keith B.
AU - Nallamothu, Brahmajee K.
AU - Krumholz, Harlan M.
AU - Curtis, Jeptha P.
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/11
Y1 - 2021/11
N2 - Background: Whether the volume of coronavirus disease 2019 (COVID-19) hospitalizations is associated with outcomes has important implications for the organization of hospital care both during this pandemic and future novel and rapidly evolving high-volume conditions. Methods: We identified COVID-19 hospitalizations at US hospitals in the American Heart Association COVID-19 Cardiovascular Disease Registry with ≥10 cases between January and August 2020. We evaluated the association of COVID-19 hospitalization volume and weekly case growth indexed to hospital bed capacity, with hospital risk-standardized in-hospital case-fatality rate (rsCFR). Results: There were 85 hospitals with 15,329 COVID-19 hospitalizations, with a median hospital case volume was 118 (interquartile range, 57, 252) and median growth rate of 2 cases per 100 beds per week but varied widely (interquartile range: 0.9 to 4.5). There was no significant association between overall hospital COVID-19 case volume and rsCFR (rho, 0.18, P = .09). However, hospitals with more rapid COVID-19 case-growth had higher rsCFR (rho, 0.22, P = 0.047), increasing across case growth quartiles (P trend = .03). Although there were no differences in medical treatments or intensive care unit therapies (mechanical ventilation, vasopressors), the highest case growth quartile had 4-fold higher odds of above median rsCFR, compared with the lowest quartile (odds ratio, 4.00; 1.15 to 13.8, P = .03). Conclusions: An accelerated case growth trajectory is a marker of hospitals at risk of poor COVID-19 outcomes, identifying sites that may be targets for influx of additional resources or triage strategies. Early identification of such hospital signatures is essential as our health system prepares for future health challenges.
AB - Background: Whether the volume of coronavirus disease 2019 (COVID-19) hospitalizations is associated with outcomes has important implications for the organization of hospital care both during this pandemic and future novel and rapidly evolving high-volume conditions. Methods: We identified COVID-19 hospitalizations at US hospitals in the American Heart Association COVID-19 Cardiovascular Disease Registry with ≥10 cases between January and August 2020. We evaluated the association of COVID-19 hospitalization volume and weekly case growth indexed to hospital bed capacity, with hospital risk-standardized in-hospital case-fatality rate (rsCFR). Results: There were 85 hospitals with 15,329 COVID-19 hospitalizations, with a median hospital case volume was 118 (interquartile range, 57, 252) and median growth rate of 2 cases per 100 beds per week but varied widely (interquartile range: 0.9 to 4.5). There was no significant association between overall hospital COVID-19 case volume and rsCFR (rho, 0.18, P = .09). However, hospitals with more rapid COVID-19 case-growth had higher rsCFR (rho, 0.22, P = 0.047), increasing across case growth quartiles (P trend = .03). Although there were no differences in medical treatments or intensive care unit therapies (mechanical ventilation, vasopressors), the highest case growth quartile had 4-fold higher odds of above median rsCFR, compared with the lowest quartile (odds ratio, 4.00; 1.15 to 13.8, P = .03). Conclusions: An accelerated case growth trajectory is a marker of hospitals at risk of poor COVID-19 outcomes, identifying sites that may be targets for influx of additional resources or triage strategies. Early identification of such hospital signatures is essential as our health system prepares for future health challenges.
KW - COVID-19
KW - Health services research
KW - Outcomes research
KW - Quality of care
KW - SARS-CoV2
UR - http://www.scopus.com/inward/record.url?scp=85114768489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114768489&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2021.06.034
DO - 10.1016/j.amjmed.2021.06.034
M3 - Article
C2 - 34343515
AN - SCOPUS:85114768489
SN - 0002-9343
VL - 134
SP - 1380-1388.e3
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 11
ER -